Company Filing History:
1 out of 37 
1 out of 1 Years Active: 1993
Title: The Innovations of Yoshiyuki Tsuji
Introduction
Yoshiyuki Tsuji is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for contraception and infertility treatment in human females.
Latest Patents
Tsuji holds a patent for the monoclonal antibody NUH2, which is capable of inactivating the motility of human sperm. This antibody is produced by a hybridoma with the ATCC deposit number HB 9762. The patent also describes an isolated antigen that specifically binds to anti-human sperm antibodies, including NUH2, and comprises at least an epitope with a sialyl I structure. Additionally, the patent covers methods for using the monoclonal antibody and antigen for contraception and treating infertility in women.
Career Highlights
Throughout his career, Tsuji has worked with reputable institutions such as the Biomembrane Institute and Hyogo Medical College. His research has been pivotal in advancing our understanding of reproductive health and the potential for targeted therapies.
Collaborations
Tsuji has collaborated with notable colleagues, including Edward D. Nudelman and Tokio Kaizu. Their combined expertise has contributed to the success of various research projects and innovations in the field.
Conclusion
Yoshiyuki Tsuji's work in developing monoclonal antibodies represents a significant advancement in biotechnology. His contributions have the potential to impact reproductive health and infertility treatments, showcasing the importance of innovation in this field.